{
    "organizations": [],
    "uuid": "3b3d9a2d23f125a08fd3d618f35734bf6db6c099",
    "author": "Reuters Editorial",
    "url": "https://www.reuters.com/article/brief-leap-therapeutics-reports-qtrly-lo/brief-leap-therapeutics-reports-qtrly-loss-per-share-of-0-85-idUSASC0A1R4",
    "ord_in_thread": 0,
    "title": "BRIEF-Leap Therapeutics Reports Qtrly Loss Per Share Of $0.85",
    "locations": [],
    "highlightText": "",
    "language": "english",
    "persons": [],
    "text": "May 11 (Reuters) - Leap Therapeutics Inc:\n* LEAP THERAPEUTICS REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS\n* QTRLY LOSS PER SHARE $0.85 * CASH, CASH EQUIVALENTS AND MARKETABLE SECURITIES TOTALED $35.4 MILLION AT MARCH 31, 2018 Source text for Eikon: Further company coverage:\n ",
    "published": "2018-05-11T19:10:00.000+03:00",
    "crawled": "2018-05-12T17:36:15.000+03:00",
    "highlightTitle": "",
    "preprocessed_text": [
        "may",
        "reuters",
        "leap",
        "therapeutic",
        "inc",
        "leap",
        "therapeutic",
        "report",
        "first",
        "quarter",
        "financial",
        "result",
        "qtrly",
        "loss",
        "per",
        "share",
        "cash",
        "cash",
        "equivalent",
        "marketable",
        "security",
        "totaled",
        "million",
        "march",
        "source",
        "text",
        "eikon",
        "company",
        "coverage"
    ]
}